English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Fludarabine (F-ara-A) is a purine analog commonly used in the treatment of indolent B cell malignancies that interferes with different aspects of DNA and RNA synthesis. K V 1.3 K +  channels are membrane proteins involved in the maintenance of K +  homeostasis and the resting potential of the cell, thus controlling signaling events, proliferation and apoptosis in lymphocytes. Here we show that F-ara-A inhibits K V  currents in human B lymphocytes. Our data indicate that K V 1.3 is expressed in both BL2 and Dana B cell lines, although total K V 1.3 levels were higher in BL2 than in Dana cells. However, K V  currents in the plasma membrane were similar in both cell lines and were abrogated by the specific K V 1.3 channel inhibitor PAP-1, indicating that K V 1.3 accounts for most of the K V  currents in these cell lines. F-ara-A, at a concentration (3.5 μM) similar to that achieved in the plasma of fludarabine phosphate-treated patients (3 μM), inhibited K V 1.3 currents by 61 ± 6.3% and 52.3 ± 6.3% in BL2 and Dana B cells, respectively. The inhibitory effect of F-ara-A was concentration-dependent and showed an  IC 50   value of 0.36 ± 0.04 μM and a  n H   value of 1.07 ± 0.15 in BL2 cells and 0.34 ± 0.13 μM ( IC 50  ) and 0.77 ± 0.11 ( n H  ) in Dana cells. F-ara-A inhibition of plasma membrane K V 1.3 was observed irrespective of its cytotoxic effect on the cells, BL2 cells being sensitive and Dana cells resistant to F-ara-A cytotoxicity. Interestingly, PAP-1, at concentrations as high as 10 μM, did not affect the viability of BL2 and Dana cells, indicating that blockage of K V 1.3 in these cells is not toxic. Finally, F-ara-A had no effect on ectopically expressed K V 1.3 channels, suggesting an indirect mechanism of current inhibition. In summary, our results describe the inhibitory effect of F-ara-A on the activity of K V 1.3 channel. Although K V 1.3 inhibition is not sufficient to induce cell death, further research is needed to determine whether it might still contribute to F-ara-A cytotoxicity in sensitive cells or be accountable for some of the clinical side effects of the drug.

Fludarabine Inhibits KV1.3 Currents in Human B Lymphocytes